6th July 2026, Monday

TechPharus

Latest Posts

HealthTech News

  • Researchers discover treatable cause of severe anemia associated with a cancer therapy
    on July 6, 2026 at 4:40 pm

    Researchers at the Mount Sinai Tisch Cancer Center have identified a previously underrecognized folate deficiency that may cause severe anemia in some patients receiving PARP inhibitors, a widely used class of targeted cancer therapies. Their findings, published in the latest issue of the journal Blood Red Cells & Iron, suggest that routine screening and treatment with folic acid could help many patients avoid blood transfusions, hospitalizations and interruptions to their cancer treatment.

  • Men may be more likely than women to receive later-stage diagnoses for many cancer types in the US
    on July 6, 2026 at 4:20 pm

    Between 2015 and 2022, men were more likely than women to be diagnosed with regional and/or distant stages of 20 nonreproductive solid cancer types in the United States, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research (AACR).

  • Researchers discover molecular ‘switch’ that simultaneously manages touch and pain
    on July 6, 2026 at 4:20 pm

    A research team led by Prof. Hyosang Lee of the Department of Brain Sciences at DGIST has identified TWIK-1, a type of potassium channel expressed in the spinal cord and peripheral sensory neurons of the somatosensory system, as a key molecular regulator of touch sensation and chronic pain. The study is significant because it presents a new molecular mechanism in the spinal cord that regulates touch responses and reveals the cause of persistent neuropathic pain, an intractable disorder, as well as a therapeutic target. The paper is published in the journal Signal Transduction and Targeted Therapy.

  • Brain tumor vaccine links mutation targeting to eight-year survival gains
    on July 6, 2026 at 4:00 pm

    A novel vaccination strategy against certain malignant brain tumors could fundamentally improve treatment for patients. Researchers from the German Cancer Research Center (DKFZ), Mannheim University Medical Center, Heidelberg University Hospital and numerous partner institutions have published encouraging long-term results from a clinical trial involving a vaccine that activates the immune system against a common genetic mutation in these tumors.

  • Is AI ready to take over your prescriptions? Doctors are wary of Utah’s automated refill program
    on July 6, 2026 at 4:00 pm

    A prescription refill program that quietly launched in Utah earlier this year has kicked off a big medical debate: Is artificial intelligence ready to take over tasks that, until now, could only be performed by doctors?